UBS Maintains Buy on Ambev, Lowers Price Target to $2.9
Portfolio Pulse from Benzinga Newsdesk
UBS maintains its Buy rating on Ambev (NYSE:ABEV) but lowers the price target from $3.2 to $2.9.
July 31, 2024 | 3:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS maintains its Buy rating on Ambev but lowers the price target from $3.2 to $2.9, indicating a slightly less optimistic outlook.
While UBS continues to recommend buying Ambev, the lowered price target suggests a tempered outlook on the stock's potential. This could lead to a neutral short-term impact as the Buy rating is positive but the reduced target price may cause some investor caution.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100